[The mechanisms of action of etophylline-clofibrate in hyperlipidemia].
Păduraru
I
I
Disciplina de Biochimie, Universitatea de Medicină şi Farmacie Iaşi.
Nechifor
M
M
Dănilă
G
G
Jercă
L
L
Filip
M
M
Iacobovici
A
A
Teslaru
E
E
Filip
C
C
Saramet
A
A
D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use*; D002994:Clofibrate / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D004176:Dipyridamole / Q000627:therapeutic use; D004353:Drug Evaluation, Preclinical; D006937:Hypercholesterolemia / Q000097:blood / Q000188:drug therapy; D006949:Hyperlipidemias / Q000097:blood / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D013806:Theophylline / Q000031:analogs & derivatives*; D014810:Vitamin E / Q000627:therapeutic use
D000975:Antioxidants; D000960:Hypolipidemic Agents; D014810:Vitamin E; C028764:etofylline clofibrate; D004176:Dipyridamole; D013806:Theophylline; D002994:Clofibrate; C008749:etofylline
Cercetări privind mecanismele de acţiune ale etofilin-clofibratului in condiţii de hiperlipidemie.